Tampere University Hospital / Tampere University
Tampere, 33521, Finland
NCT Number: NCT03136731
Main aim: To find evidence-based screening strategies for celiac disease in high risk groups and to find new biomarkers or biomarker combinations for celiac disease diagnostics and follow-up.
Interested in participating?
Request Info6 month–100 year
All sexes
Observational
Tampere, 33521, Finland
The current project will result in the identification of genetic, environmental or downstream biomedical markers that predict the development of celiac disease at the individual level. Moreover, the markers can be exploited in prediction of specific disease risks, manifestations, comorbidities and complications.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational parameters
Time frame: With in 10 years
Assessed by positive transglutaminase antibodies, small bowel mucosal villous atrophy
Katri Kaukinen
Other
Improving Case-finding Strategies for Celiac Disease in Family Members: a Follow-up Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06657001
Celiac Disease, Colitis
Rochester, Minnesota, United States
View Trial DetailsNCT02202681
Celiac Disease, Digestive System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05204446
Celiac Disease, Digestive System Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05084937
Celiac Disease, Celiac Disease in Children
Kuopio, Finland
View Trial Details